|
|
||||||||


* Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria, Australia;
Department of Infectious Diseases, St. Jude Childrens Research Hospital, Memphis, TN 38105; and
Department of Immunology, St. Jude Childrens Research Hospital, Memphis, TN 38105
A reverse genetics strategy was used to insert the OVA peptide (amino acid sequence SIINFEKL; OVA257264) into the neuraminidase stalk of both the A/PR8 (H1N1) and A/HKx31 (H3N2) influenza A viruses. Initial characterization determined that KbOVA257 is presented on targets infected with PR8-OVA and HK-OVA without significantly altering Db nucleoprotein (NP)366 presentation. There were similar levels of KbOVA257- and DbNP366-specific CTL expansion following both primary and secondary intranasal challenge. Interestingly, while variable, the presence of the immunodominant KbOVA257-specific response resulted in diminished Db acidic polymerase224- and Kb basic polymerase subunit 1703-, but not DbNP366-specific responses and didnt alter endogenous influenza A virus-specific immunodominance hierarchies. However, challenging PR8-OVA-primed mice with HK-OVA via the i.p. route, and thereby limiting Ag dose, led to a reduction in the magnitude of all the influenza A virus-specific responses measured. A similar reduction in CTL response to native epitopes was also seen following primary respiratory HK-OVA infection of mice that received substantial numbers of KbOVA257-specific TCR transgenic T cells. Thus, during the course of infection, the generation of individual virus-specific CTL responses is independently regulated. However, in cases in which Ag is limiting, or high precursor frequency, the presence of immunodominant CTL responses can impact on the magnitude of other specific populations. Therefore, depending on both the size of the T cell precursor pool and the mode of Ag presentation, the addition of a major epitope can diminish the size of endogenous, influenza-specific CD8+ T cell responses, although never to the point that these are totally compromised.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by an Australian Postgraduate Scholarship awarded to M.R.J.; a National Health and Medical Research Council Burnet Fellowship awarded to P.C.D.; a National Health and Medical Research Council RD Wright Fellowship awarded to S.J.T.; Science Technology, Innovation funds from the Government of Victoria, Australia; and U.S. Public Health Service Grants AI29579 and ALSAC at St. Jude Childrens Research Hospital.
2 Address correspondence and reprint requests to Dr. Stephen J. Turner, Department of Microbiology and Immunology, University of Melbourne, Parkville, Victoria 3010, Australia. E-mail address: sjturn{at}unimelb.edu.au
3 Abbreviations used in this paper: Tg, transgenic; BAL, bronchoalveolar lavage; i.n., intranasal; MDCK, Madin-Darby canine kidney; NA, neuraminidase; NP, nucleoprotein; PA, acidic polymerase; PB1, basic polymerase subunit 1.
This article has been cited by other articles:
![]() |
L. E. Valentine, J. T. Loffredo, A. T. Bean, E. J. Leon, C. E. MacNair, D. R. Beal, S. M. Piaskowski, Y. C. Klimentidis, S. M. Lank, R. W. Wiseman, et al. Infection with "Escaped" Virus Variants Impairs Control of Simian Immunodeficiency Virus SIVmac239 Replication in Mamu-B*08-Positive Macaques J. Virol., November 15, 2009; 83(22): 11514 - 11527. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lev, P. Dimberu, S. R. Das, J. C. Maynard, C. V. Nicchitta, J. R. Bennink, and J. W. Yewdell Efficient Cross-Priming of Antiviral CD8+ T Cells by Antigen Donor Cells Is GRP94 Independent J. Immunol., October 1, 2009; 183(7): 4205 - 4210. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Moltedo, C. B. Lopez, M. Pazos, M. I. Becker, T. Hermesh, and T. M. Moran Cutting Edge: Stealth Influenza Virus Replication Precedes the Initiation of Adaptive Immunity J. Immunol., September 15, 2009; 183(6): 3569 - 3573. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sexton, R. De Rose, J. C. Reece, S. Alcantara, L. Loh, J. M. Moffat, K. Laurie, A. Hurt, P. C. Doherty, S. J. Turner, et al. Evaluation of Recombinant Influenza Virus-Simian Immunodeficiency Virus Vaccines in Macaques J. Virol., August 1, 2009; 83(15): 7619 - 7628. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Mintern, S. Bedoui, G. M. Davey, J. M. Moffat, P. C. Doherty, and S. J. Turner Transience of MHC Class I-restricted antigen presentation after influenza A virus infection PNAS, April 21, 2009; 106(16): 6724 - 6729. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Grebe, H. D. Hickman, K. R. Irvine, K. Takeda, J. R. Bennink, and J. W. Yewdell Sympathetic nervous system control of anti-influenza CD8+ T cell responses PNAS, March 31, 2009; 106(13): 5300 - 5305. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. H. Y. Lin, B. J. Sedgmen, T. J. Moraes, L. M. Snell, D. J. Topham, and T. H. Watts Endogenous 4-1BB Ligand Plays a Critical Role in Protection from Influenza-Induced Disease J. Immunol., January 15, 2009; 182(2): 934 - 947. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ingulli, C. Funatake, E. L. Jacovetty, and M. Zanetti Cutting Edge: Antigen Presentation to CD8 T Cells after Influenza A Virus Infection J. Immunol., January 1, 2009; 182(1): 29 - 33. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Jenkins, J. Mintern, N. L. La Gruta, K. Kedzierska, P. C. Doherty, and S. J. Turner Cell Cycle-Related Acquisition of Cytotoxic Mediators Defines the Progressive Differentiation to Effector Status for Virus-Specific CD8+ T Cells J. Immunol., September 15, 2008; 181(6): 3818 - 3822. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. F. Kotturi, I. Scott, T. Wolfe, B. Peters, J. Sidney, H. Cheroutre, M. G. von Herrath, M. J. Buchmeier, H. Grey, and A. Sette Naive Precursor Frequencies and MHC Binding Rather Than the Degree of Epitope Diversity Shape CD8+ T Cell Immunodominance J. Immunol., August 1, 2008; 181(3): 2124 - 2133. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Castiglioni, D. S. Hall, E. L. Jacovetty, E. Ingulli, and M. Zanetti Protection against Influenza A Virus by Memory CD8 T Cells Requires Reactivation by Bone Marrow-Derived Dendritic Cells J. Immunol., April 1, 2008; 180(7): 4956 - 4964. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kastenmuller, G. Gasteiger, J. H. Gronau, R. Baier, R. Ljapoci, D. H. Busch, and I. Drexler Cross-competition of CD8+ T cells shapes the immunodominance hierarchy during boost vaccination J. Exp. Med., September 3, 2007; 204(9): 2187 - 2198. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kedzierska, J. Stambas, M. R. Jenkins, R. Keating, S. J. Turner, and P. C. Doherty Location rather than CD62L phenotype is critical in the early establishment of influenza-specific CD8+ T cell memory PNAS, June 5, 2007; 104(23): 9782 - 9787. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |